|
Showing posts with label minor autohemotherapy. Show all posts
Showing posts with label minor autohemotherapy. Show all posts
Tuesday, 27 September 2016
Our September 2016 Newsletter
Friday, 8 July 2016
Minor Autohemotherapy can be a life saver
There is (always) huge hype around adjunct, alternate or
complementary therapies – especially when they work!
One can trawl the internet and find many
testimonials from people who have been cured of diseases from diabetes to
cancer through anything from eating papaya pips to drinking hydrogen peroxide.
At The Ozone Pod, we have seen amazing results with our
patients undergoing minor Autohemotherapy (mAHT) treatment.
In fact, one of our patients with Stage III lung cancer
who refused chemotherapy and other conventional treatments, and who was given
a very poor prognosis at the time of diagnosis, has been called a ‘medical
miracle’ by the doctor who gave him the bad news in February 2016. This patient is being treated by us with, amongst other protocols, mAHT infused with Ozone. His scans two weeks ago showed impressive healing - the results of
our team-work with him. Not only has the
cancer growth been stopped, but his lung function is so good, the
intern at the hospital he went to told him to ‘carry on doing whatever it is
you are doing’.
So he is coming back next week for continued treatment with
us.
What is Autohemotherapy?
Autohemotherapy is the immediate intramuscular, or
subcutaneous reinjection of freshly drawn autologous blood. Autologous blood means we use the patients own blood as opposed to allogenic blood - that which is received from a donor (as
used in blood transfusions).
An effective way to administer mAHT is with the addition of
Ozone.
The ozone fragments most virions
without regard to preserving cellular elements.
Once injected intramuscularly, the treated blood carries these fragments
of viral envelope and nuleic acids through the general circulation of the body
and into the immune network. If the
immune network is relatively operational, it begins to manufacture appropriate
antibodies which in turn, serve to counter the evolution of any infection.
The benefit of using this technique is that the antibodies
which are manufactured, are individualized to the patient since they are
derived from their own viral or bacterial stock. mAHT can thus be conceptualized as a method
of auto-vaccination, providing a high degree of antibody specificity.
In patients who have been ill for a long time, the first
line of defence has most often been weakened.
Ozone mAHT specifically stimulates the body’s second line of defence
which is so important in autoimmune diseases and long-term chronic
illnesses. It has the ability to
reactivate the body’s natural killer cells.
How Is It Administered?
It is a quick procedure where a small amount of blood is
taken from the patient’s vein. It is
then enriched in another syringe containing ozone. This enriched blood is then injected into the
patient’s gluteal muscle, or sometimes under the patient’s skin.
Minor Autohemotherapy has proven itself to be of great value
as a non-specific immune-activator with benefits in any condition where
increased immune activity is desired.
The treatment process lasts about 10 minutes and can be
carried out three or more times per week, dependent on the patient’s condition.
During June 2016, we have Dr Mitch holding an mAHT Clinic at The Ozone Pod. Make your appointments now by calling us on 011 465 4514
Subscribe to:
Posts (Atom)